Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 3 boards, counting each seat separately. Longest: Geron Corporation, 3 years.
Geron Corporation
Director
Veracyte Inc.
Director
Personalis Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 13, 2024 | Veracyte Inc. | Grant or award | +11,473 | — | — |
| Jun 11, 2024 | Veracyte Inc. | Open-market sale | −3,870 | $20.59 | $79,683 |
| Jun 7, 2024 | Veracyte Inc. | Option exercise | +2,500 | $10.41 | $26,025 |
| Jun 7, 2024 | Veracyte Inc. | Open-market sale | −2,500 | $20.97 | $52,425 |
| Apr 1, 2024 | Veracyte Inc. | Option exercise | +10,000 | $13.19 | $131,900 |
| Apr 1, 2024 | Veracyte Inc. | Open-market sale | −10,000 | $21.65 | $216,500 |
| Jun 9, 2023 | Veracyte Inc. | Grant or award | +9,674 | — | — |
| Mar 16, 2023 | Veracyte Inc. | Option exercise | +18,750 | $12.12 | $227,250 |
| Mar 16, 2023 | Veracyte Inc. | Open-market sale | −18,750 | $22.78 | $427,125 |
| Feb 28, 2023 | Veracyte Inc. | Option exercise | +10,000 | $12.12 | $121,200 |
| Feb 28, 2023 | Veracyte Inc. | Open-market sale | −10,000 | $25.00 | $250,000 |
| Jan 13, 2023 | Geron Corporation | Option exercise | +35,000 | $1.10 | $38,500 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.